Publicité
La bourse ferme dans 1 h 29 min

  • CAC 40

    7 992,09
    +10,58 (+0,13 %)
     

  • Euro Stoxx 50

    4 916,69
    +2,56 (+0,05 %)
     

  • Dow Jones

    37 945,99
    +192,68 (+0,51 %)
     

  • EUR/USD

    1,0653
    -0,0022 (-0,20 %)
     

  • Gold future

    2 397,40
    +9,00 (+0,38 %)
     

  • Bitcoin EUR

    58 986,88
    +144,27 (+0,25 %)
     

  • CMC Crypto 200

    885,54
    0,00 (0,00 %)
     

  • Pétrole WTI

    82,79
    +0,10 (+0,12 %)
     

  • DAX

    17 744,80
    -25,22 (-0,14 %)
     

  • FTSE 100

    7 853,27
    +5,28 (+0,07 %)
     

  • Nasdaq

    15 648,47
    -34,90 (-0,22 %)
     

  • S&P 500

    5 025,59
    +3,38 (+0,07 %)
     

  • Nikkei 225

    38 079,70
    +117,90 (+0,31 %)
     

  • HANG SENG

    16 385,87
    +134,03 (+0,82 %)
     

  • GBP/USD

    1,2446
    -0,0010 (-0,08 %)
     

The Global Central Nervous System Disorders Therapeutics Market is expected to grow by $ 23.16 bn during 2020-2024 progressing at a CAGR of 4% during the forecast period

ReportLinker
·2 min de lecture

Global Central Nervous System Disorders Therapeutics Market 2020-2024 The analyst has been monitoring the central nervous system disorders therapeutics market and it is poised to grow by $ 23.

New York, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Central Nervous System Disorders Therapeutics Market 2020-2024" - https://www.reportlinker.com/p04188423/?utm_source=GNW
16 bn during 2020-2024 progressing at a CAGR of 4% during the forecast period. Our reports on central nervous system disorders therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of CNS disorders and increasing awareness programs. In addition, the increasing prevalence of CNS disorders is anticipated to boost the growth of the market as well.
The central nervous system disorders therapeutics market analysis includes the type segment and geographical landscapes.

The central nervous system disorders therapeutics market is segmented as below:
By Type
• Depression drugs
• Multiple sclerosis drugs
• Schizophrenia drugs
• Bipolar disorder therapeutics
• Other types

By Geographical Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the special regulatory designations for CNS disorders as one of the prime reasons driving the central nervous system disorders therapeutics market growth during the next few years.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our central nervous system disorders therapeutics market covers the following areas:
• Central nervous system disorders therapeutics market sizing
• Central nervous system disorders therapeutics market forecast
• Central nervous system disorders therapeutics market industry analysis


Read the full report: https://www.reportlinker.com/p04188423/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001